Have your own idea? Try our Stock Screener
Italian (Borsa Italiana) Biotech Industry Analysis
UpdatedNov 25, 2025
DataAggregated Company Financials
Companies3
- 7D1.7%
- 3M2.2%
- 1Y26.6%
- YTD25.3%
In the last week, the Biotech industry is up 3.8%, with Philogen up 4.2%. This takes the industry's 12 month performance to a gain of 27%. As for the next few years, earnings are forecast to decline by 75% per annum.
Industry Valuation and Performance
Has the Italian Biotech Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sat, 29 Nov 2025 | €997.8m | €89.8m | €41.9m | 17.9x | 23.8x | 11.1x |
| Mon, 27 Oct 2025 | €1.0b | €89.8m | €41.9m | 18.3x | 24x | 11.2x |
| Wed, 24 Sep 2025 | €977.2m | €82.6m | €40.7m | 17.2x | 24x | 11.8x |
| Fri, 22 Aug 2025 | €990.7m | €82.6m | €40.7m | 16.9x | 24.3x | 12x |
| Sun, 20 Jul 2025 | €946.6m | €82.6m | €40.7m | 16.4x | 23.3x | 11.5x |
| Tue, 17 Jun 2025 | €1.1b | €82.6m | €40.7m | 17.7x | 27.4x | 13.5x |
| Thu, 15 May 2025 | €958.5m | €82.1m | €40.7m | 15.8x | 23.6x | 11.7x |
| Sat, 12 Apr 2025 | €867.3m | €82.1m | €40.7m | 14.5x | 21.3x | 10.6x |
| Mon, 10 Mar 2025 | €780.2m | €8.0m | -€34,970,729.00 | 10.3x | -22.3x | 97.7x |
| Wed, 05 Feb 2025 | €756.1m | €8.0m | -€34,970,729.00 | 9.6x | -21.6x | 94.7x |
| Fri, 03 Jan 2025 | €804.4m | €8.0m | -€34,970,729.00 | 9.7x | -23x | 100.8x |
| Sun, 01 Dec 2024 | €796.0m | €8.0m | -€34,970,729.00 | 9.4x | -22.8x | 99.7x |
| Tue, 29 Oct 2024 | €867.7m | €8.0m | -€34,970,729.00 | 9.8x | -24.8x | 108.7x |
| Thu, 26 Sep 2024 | €837.3m | €28.1m | -€9,881,696.00 | 11.6x | -84.7x | 29.8x |
| Sat, 24 Aug 2024 | €914.5m | €28.1m | -€9,881,696.00 | 12.9x | -92.5x | 32.5x |
| Mon, 22 Jul 2024 | €874.4m | €28.1m | -€9,881,696.00 | 13.2x | -88.5x | 31.1x |
| Wed, 19 Jun 2024 | €841.8m | €29.3m | -€9,973,872.00 | 13.1x | -84.4x | 28.7x |
| Fri, 17 May 2024 | €766.2m | €29.4m | -€6,852,735.00 | 13.3x | -111.8x | 26.1x |
| Sun, 14 Apr 2024 | €775.1m | €29.4m | -€6,852,735.00 | 13.7x | -113.1x | 26.4x |
| Tue, 12 Mar 2024 | €763.8m | €33.9m | -€375,735.00 | 1142.1x | -2032.9x | 22.6x |
| Thu, 08 Feb 2024 | €727.2m | €33.9m | -€375,735.00 | 1083.7x | -1935.3x | 21.5x |
| Sat, 06 Jan 2024 | €752.3m | €33.9m | -€375,735.00 | 1154.1x | -2002.2x | 22.2x |
| Mon, 04 Dec 2023 | €760.2m | €33.9m | -€375,735.00 | 1169.7x | -2023.3x | 22.4x |
| Wed, 01 Nov 2023 | €725.0m | €33.9m | -€375,735.00 | 1115.8x | -1929.5x | 21.4x |
| Fri, 29 Sep 2023 | €493.8m | €31.9m | -€5,269,721.00 | 8x | -93.7x | 15.5x |
| Sun, 27 Aug 2023 | €498.9m | €31.9m | -€5,269,721.00 | 9.8x | -94.7x | 15.6x |
| Tue, 25 Jul 2023 | €493.2m | €31.9m | -€5,269,721.00 | 11.1x | -93.6x | 15.5x |
| Thu, 22 Jun 2023 | €490.9m | €32.4m | -€5,269,721.00 | 11x | -93.2x | 15.2x |
| Sat, 20 May 2023 | €464.7m | €32.4m | -€5,269,721.00 | 10.5x | -88.2x | 14.3x |
| Mon, 17 Apr 2023 | €484.6m | €33.0m | -€5,008,797.00 | 11.9x | -96.7x | 14.7x |
| Wed, 15 Mar 2023 | €506.0m | €28.7m | -€4,740,218.00 | 11.4x | -106.8x | 17.6x |
| Fri, 10 Feb 2023 | €470.8m | €28.7m | -€4,740,218.00 | 11.8x | -99.3x | 16.4x |
| Sun, 08 Jan 2023 | €429.0m | €28.7m | -€4,740,218.00 | 11.3x | -90.5x | 15x |
| Tue, 06 Dec 2022 | €432.9m | €28.7m | -€4,740,218.00 | 10.5x | -91.3x | 15.1x |
Price to Earnings Ratio
-91.3x
Current Industry PE
- There are only 3 companies in the Italian Biotechs industry, so there is insufficient data to make an industry-wide assessment of both the PE and PS ratio.
Past Earnings Growth
- Total earnings for the Biotechs industry have gone up over the last three years, and the industry is now profitable. Revenues have grown 46% per year.
- This means that more sales are being generated by the industry overall, and subsequently profits are increasing too.
Industry Trends
Which industries have driven the changes within the Italian Healthcare industry?
| IT Market | 1.59% | |
| Healthcare | 1.50% | |
| Biotech | 1.66% | |
| Biotech | 1.66% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| PHIL Philogen | €24.10 | 1.7% +€16.1m | 26.8% | PE21.1x | |
| UBM Ulisse Biomed | €0.80 | 1.3% +€244.8k | -1.2% | PS21.2x | |
| ARBS Arterra Bioscience | €2.98 | 0.7% +€133.2k | 56.8% | PE14.8x |